JPWO2021201171A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021201171A5
JPWO2021201171A5 JP2022512664A JP2022512664A JPWO2021201171A5 JP WO2021201171 A5 JPWO2021201171 A5 JP WO2021201171A5 JP 2022512664 A JP2022512664 A JP 2022512664A JP 2022512664 A JP2022512664 A JP 2022512664A JP WO2021201171 A5 JPWO2021201171 A5 JP WO2021201171A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
compound
group
composition according
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022512664A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021201171A1 (https=
JP7699831B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/014030 external-priority patent/WO2021201171A1/ja
Publication of JPWO2021201171A1 publication Critical patent/JPWO2021201171A1/ja
Publication of JPWO2021201171A5 publication Critical patent/JPWO2021201171A5/ja
Application granted granted Critical
Publication of JP7699831B2 publication Critical patent/JP7699831B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022512664A 2020-04-01 2021-03-31 神経炎症の抑制、そのための組成物及び方法 Active JP7699831B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020066150 2020-04-01
JP2020066150 2020-04-01
PCT/JP2021/014030 WO2021201171A1 (ja) 2020-04-01 2021-03-31 神経炎症の抑制、そのための組成物及び方法

Publications (3)

Publication Number Publication Date
JPWO2021201171A1 JPWO2021201171A1 (https=) 2021-10-07
JPWO2021201171A5 true JPWO2021201171A5 (https=) 2022-12-20
JP7699831B2 JP7699831B2 (ja) 2025-06-30

Family

ID=77929171

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022512664A Active JP7699831B2 (ja) 2020-04-01 2021-03-31 神経炎症の抑制、そのための組成物及び方法

Country Status (5)

Country Link
US (1) US12605368B2 (https=)
EP (1) EP4129340B1 (https=)
JP (1) JP7699831B2 (https=)
CN (1) CN115361973A (https=)
WO (1) WO2021201171A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9745323B2 (en) 2012-07-30 2017-08-29 Kyoto University Compound and pharmaceutical composition for neuropsychological disorder or malignant tumor
CA2912345C (en) 2013-05-16 2020-10-06 Sumitomo Dainippon Pharma Co., Ltd. Transplantation adjuvant in cell therapy using neural progenitor cells
JP2015107945A (ja) 2013-12-05 2015-06-11 国立大学法人京都大学 神経新生に関する化合物及び医薬組成物
WO2015107945A1 (ja) 2014-01-17 2015-07-23 ソニー株式会社 スイッチ素子および記憶装置
CN106535890A (zh) 2014-03-20 2017-03-22 萨穆梅德有限公司 5‑取代的吲唑‑3‑羧酰胺及其制备和应用
WO2018029793A1 (ja) 2016-08-09 2018-02-15 株式会社Aob慧央グループ Il-6産生抑制剤、抗炎症剤、抗神経変性疾患剤、抗精神神経疾患剤、医薬品及び食品
WO2018043674A1 (ja) 2016-08-31 2018-03-08 国立大学法人京都大学 神経新生を活性化するための組成物
US10604514B2 (en) 2017-10-19 2020-03-31 Samumed, Llc 6-(5-membered heteroaryl)isoquinolin-3-yl carboxamides and preparation and use thereof

Similar Documents

Publication Publication Date Title
JP3302018B2 (ja) N,n’−ジアセチルシスチンの有機塩
JP5555240B2 (ja) 新規の窒素含有複素環化合物、それらの調製、および抗菌薬としての使用
JP2004516278A (ja) 一酸化窒素合成酵素阻害物質であるリン酸塩
RU2011106948A (ru) Новые производные оксима холест-4-ен-3-она, фармацевтические композиции, их содержащие, и способ получения
JP2013502430A5 (https=)
JP2008520589A5 (https=)
JP2013540776A5 (https=)
JP2021519787A (ja) 6−アミノイソキノリンのモノ酸塩及びその使用
JP2022543244A5 (https=)
WO2017112853A1 (en) Methods of treating pulmonary diseases and disorders
JP2007522162A5 (https=)
JP2008505100A5 (https=)
JP2023544716A5 (https=)
WO2021000785A1 (zh) 作为詹纳斯激酶1选择抑制剂的吡咯并[2,3-b]吡啶衍生物
JP2011518168A5 (https=)
CN101506145B (zh) 氨基醇衍生物以及将它们作为有效成分的免疫抑制剂
JP2022523332A5 (ja) 近視を治療するための化合物、組成物及び医薬組成物
JP2008536844A5 (https=)
JPWO2021201171A5 (https=)
KR102925234B1 (ko) 공유 에피토프-칼레티쿨린 상호 작용의 소분자 억제제 및 사용 방법
HUP9702481A2 (hu) Új N-benzil-piperazin-vegyületek, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
EP4108240A2 (en) Benzimidazole derivatives for treatment and/or prevention of diseases and disorders mediated by nlrp3
JP2004501079A5 (https=)
JP7382944B2 (ja) 神経変性疾患を予防・治療するための新規な化合物及びその応用
JP2008239546A (ja) アミノアルコール誘導体及びそれらを有効成分とする免疫抑制剤